Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioDelivery Sciences International Inc (NASDAQ:BDSI)

6.75
Delayed Data
As of Aug 31
 -0.12 / -1.75%
Today’s Change
5.89
Today|||52-Week Range
18.48
-43.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$360.4M

Company Description

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties. It is focusing on developing products to meet unmet patient needs in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Contact Information

BioDelivery Sciences International, Inc.
4131 ParkLake Avenue
Raleigh North Carolina 27612
P:(919) 582-9050
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Mark A. SirgoPresident, Chief Executive Officer & Director
Ernest R. de PaolantonioChief Financial Officer, Secretary & Treasurer
Niraj VasishtChief Technology Officer & SVP-Product Development
Sarah DeRossettVice President-Clinical Research & Medical Affairs
Stephana E. PattonVice President & General Counsel